Alembic Pharma Share Jumps 5% After USFDA Approves Glaucoma Drug
Shares of Alembic Pharmaceuticals rose 5% in early trading on March 31 after receiving final approval from the US Food and Drug Administration (USFDA) for...
Tag : Alembic Pharmaceuticals
Alembic Pharma Shares Down 5% as Board Approves Rs 1,150 Crore Impairment Charge
Shares of Alembic Pharmaceuticals hit a 52-week low of Rs 476.30 after the company said its board approved an impairment charge of Rs 1,150 crore...
Natco Pharma Shares Up 4% on Filing Generic Version of Oncology Drug in US
Shares of Natco Pharma rose 4.5% to Rs 549 a share in intraday trade on Monday after the company submitted a generic version of an...
Alembic Gets USFDA Approval for Cancer Treatment Drug
Alembic Pharmaceuticals said in a statement it had received approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Dasatinib tablets of 20...
Alembic Pharma Gets FDA Approval for Pirfenidone Tablets
Alembic Pharmaceuticals rose 1.03 per cent to Rs 768.20 after the company announced that it’s Abbreviated New Drug Application (ANDA) for pirfenidone tablets had received...
Alembic Pharma Unit Receives Final USFDA Approval for Generic Version of Fever Blisters
Alembic Pharmaceuticals said Wednesday that its wholly-owned subsidiary, Aleor Dermaceuticals, has received final approval from US health regulators for its generic Docosanol cream to treat...
Aleor Dermaceuticals Gets FDA Nod For Anti-Fungal Drug
Alembic Pharmaceuticals announced that its joint venture, Aleor Dermaceuticals, has got the final nod from the US health regulator Food & Drug Administration (FDA) for...
